The mythbuster: Hospital drugs spend is rising steeply and we need to know why

Steve Black 3x2

Despite the NHS’s substantial £20bn annual expenditure on drugs and devices, transparency issues persist in understanding hospital medicine budgets, hindering effective analysis and improvement efforts in the face of evolving pharmaceutical pricing agreements, writes Steve Black

Register with to read the rest of this article


Critical stories remain free for registered users

Certain articles and Insight pieces remain paying-subscriber only content

As a registered user you will get access to:

  • Daily News: an essential email round-up of all the latest news, comment and best practice
  • Breaking news headlines delivered directly to your inbox
  • Limited access to

Already registered to HSJ? Sign in now